These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9116294)

  • 1. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line.
    Gong M; Yess J; Connolly T; Ivy SP; Ohnuma T; Cowan KH; Moscow JA
    Blood; 1997 Apr; 89(7):2494-9. PubMed ID: 9116294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
    Kobayashi H; Takemura Y; Ohnuma T
    Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
    Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
    Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
    Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
    Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
    Ma D; Huang H; Moscow JA
    Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.
    Moscow JA; Gong M; He R; Sgagias MK; Dixon KH; Anzick SL; Meltzer PS; Cowan KH
    Cancer Res; 1995 Sep; 55(17):3790-4. PubMed ID: 7641195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
    Roy K; Tolner B; Chiao JH; Sirotnak FM
    J Biol Chem; 1998 Jan; 273(5):2526-31. PubMed ID: 9446553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
    Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of human acute leukemia cell line resistant to ZD9331, a non-polyglutamatable thymidylate synthase inhibitor.
    Kobayashi H; Takemura Y; Miyachi H
    Cancer Chemother Pharmacol; 1998; 42(2):105-10. PubMed ID: 9654109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
    Brigle KE; Spinella MJ; Sierra EE; Goldman ID
    J Biol Chem; 1995 Sep; 270(39):22974-9. PubMed ID: 7559435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.